IAS 2017 eSymposium EU Annenberg

IAS 2017 eSymposium EU Annenberg  

IAS 17 EU main button
 
IAS 17 EU 01

IAS 17 EU 02

IAS 17 EU 03

IAS 17 EU 04

IAS 17 EU 05

IAS 17 EU 06

 

About the Program:

Program Overview:

The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 9th IAS Conference on HIV Science (IAS 2017). This program consists of five components: (1) European Perspective on IAS 2017: a 1.5 hour Case-based Internet symposium featuring Europe-based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (2) IAS 2017 Expert Review**: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (3) Comprehensive Expert Review and Discussion of Key Presentations**: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium (4) Rapid-Fire Review of IAS 2017**: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (5) From Conference to Clinic: Reviewing and Applying Data From IAS 2017**: case-based dinner meetings during which the key data are reviewed, discussed and applied to patient care.

The European Perspective on IAS 2017 will provide a case-based, European focused review and discussion of key presentations on antiretroviral therapy presented at IAS 2017. The review and discussion will focus on HIV therapeutic options and developments, including: current treatment and management strategies, algorithms and recommendations, therapies in development, epidemiology, and diagnosis and clinical management of specific patient populations. This activity will enable EU-based health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care in the EU. All online components of the program can be accessed at www.viraled.com.

This program is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine. It is not a session created by or presented at IAS 2017 and it is not sanctioned by the organizers of IAS 2017.

** This component is produced by the Postgraduate Institute for Medicine and ViralEd, Inc and supported by an independent educational grant from Gilead Sciences Medical Affairs.

Back to Top

Target Audience:

This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.

Back to Top

Learning Objectives:

After completing this activity, the participant should be better able to:

  • Use data reported at major HIV/AIDS conferences for counselling, testing and antiretroviral treatment to prevent HIV infection in the EU
  • Use in a clinical setting findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at major HIV/AIDS conferences
  • Employ strategies based on studies and data presented in major HIV/AIDS conferences for helping HIV-positive patients in the EU link to and stay in appropriate and effective HIV care
  • Understand data and studies regarding screening, evaluation, management and treatment of HCV in HIV/HCV co-infected patients presented at major HIV/AIDS conferences and use that information to educate, diagnose, manage and treat HIV/HCV co-infected patients and those HIV patients at risk for HCV in the EU

Release Date: August 17, 2017

Expiration Date: August 17, 2018

Estimated time to complete the program: 30 - 90 minutes

Back to Top

Faculty:

José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom

Marta Boffito, MD, PhD
St. Stephen's AIDS Trust and Imperial College
Chelsea and Westminster Hospital
London, United Kingdom

Jürgen Rockstroh, MD 
Professor of Medicine
Department of Medicine I
University Hospital 
Bonn, Germany 
Jean-Michel Molina, MD, PhD
Head, Infectious Diseases Department
Hospital Saint-Louis
Paris France
Back to Top

Physician Continuing Medical Education:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

For Each Program Segment:

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For Complete Program:

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

 

Back to Top

European Continuous Medical Education Credit:

AMA PRA Category 1 CreditsTM claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 CreditsTM can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC®) granted by the UEMS. One AMA PRA Category 1 CreditTM is equivalent to one (1) hour of European EACCME Credit (ECMEC®), therefore up to 1.0 ECMEC® Credits are available.

Back to Top

Disclosure of Conflicts of Interest:

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Jose Arribas, MD

  • Consulting Fees: Merck, Gilead
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier agents (eg. speakers' bureaus): ViiV, Janssen, Abbvie, BMS, Gilead, MSD

Marta Boffito, MD

  • Consulting Fees: Gilead, BMS, ViiV
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier agents (eg. speakers' bureaus): Gilead, Janssen, ViiV, BMS
  • Contracted Research: Gilead, Janssen, ViiV, BMS

Jean-Michel Molina, MD

  • Consulting Fees: Gilead, ViiV, Merck, BMS
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier agents (eg. speakers' bureaus): Gilead

Graeme Moyle, MD

  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier agents (eg. speakers' bureaus): BMS, Gilead, Merck, Tobira/Allergen
  • Contracted Research: Teva, Mylan

Juergen Rockstroh, MD

  • Consulting Fees: Abbott, Gilead, Hexal, Merck, ViiV
  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest or thier agents (eg. speakers' bureaus): Abbot, Gilead, Janssen, Merck
  • Contracted Research: Gilead

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc; Amanda Sewell, MBA, Manager of Continuing Education and Alma Perez, Accreditation Specialist from the Annenber Center for Health Sciences at Eisenhower have not relevant commercial relationships to disclose. 

The PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, RN, BSN and Jan Shultz, RN, MSN, CHCP have nothing to disclose.

Back to Top

 

Instructions for Participation and Credit

There are no fees for participating and received CME credit for this activity.  During the period, August 17, 2017 through August 17, 2018, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 12603.  Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately.  Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

 

PIM_small          Annenberg Center For Health Science logo

VE logo 300px

 

This activity is supported by an independent educational grant from ViiV Healthcare.

This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.


Prepare to print

Share this page:

Get link code to this page                     


Back to Top